"Designing Growth Strategies is in our DNA"

Europe Pharmaceuticals Market Size, Share & Industry Analysis, By Type (Drugs {Prescription & OTC} and Vaccines {Bacterial & Viral}), By Disease Indication (Oncology, Diabetes, Infectious, Cardiovascular, Renal, Obesity, Autoimmune, Ophthalmic, Liver/Hepatology, Reproductive, Allergies), By Drug Type (Biologics & Biosimilars {Antibodies [Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates] Vaccines, Others}), By Route of Administration, By Distribution Channel (Hospitals Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI114229

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Key Industry Developments (Mergers, Acquisitions & Partnerships, etc.)
    3. Impact of COVID-19 on the Market
    4. Pipeline Analysis, By Key Players
    5. Prevalence/Incidence of Key Diseases in Europe
    6. Regulatory Framework in Europe
    7. Reimbursement Scenario in Europe
  5. Europe Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032 
    1. Market Analysis, Insights and Forecast – By Type
      1. Drugs
        1. Prescription
        2. OTC
      2. Vaccines
        1. Bacterial
        2. Viral
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Oncology
      2. Diabetes
      3. Infectious
      4. Cardiovascular
      5. Neurology & Psychiatry
      6. Respiratory
      7. Renal
      8. Obesity
      9. Autoimmune
      10. Ophthalmic
      11. Gastrointestinal
      12. Dermatology
      13. Hematology/Blood
      14. Liver/Hepatology
      15. Genetic
      16. Hormonal/Endocrine
      17. Women’s Health
      18. Reproductive
      19. Allergies
      20. Others
    3. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics & Biosimilars
        1. Antibodies
          1. Monoclonal Antibodies (mAbs)
          2. Bispecific Antibodies
          3. Antibody-Drug Conjugates (ADCs)
          4. Others
        2. Vaccines
        3. Peptides/Peptide-Drug Conjugates (PDCs)
        4. Others
      2. Small Molecules/Conventional Drugs
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
      4. Inhalation
      5. Others
    5. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies 
    7. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K. 
      2. Germany 
      3. France 
      4. Spain 
      5. Italy 
      6. Scandinavia 
      7. Rest of Europe 
  6. Competitive Analysis 
    1. Europe Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Merck & Co., Inc.
      2. Pfizer Inc.
      3. Johnson & Johnson
      4. AbbVie Inc.
      5. AstraZeneca
      6. F. Hoffmann-La Roche Ltd
      7. Novartis AG
      8. Bristol-Myers Squibb Company
      9. Eli Lilly and Company
      10. Sanofi
      11. Novo Nordisk A/S
      12. GSK plc.
      13. Amgen Inc.
      14. Gilead Sciences, Inc.
      15. Takeda Pharmaceutical Company Limited 
      16. Other Prominent Players
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Key Industry Developments (Mergers, Acquisitions & Partnerships, etc.)
    3. Impact of COVID-19 on the Market
    4. Pipeline Analysis, By Key Players
    5. Prevalence/Incidence of Key Diseases in Europe
    6. Regulatory Framework in Europe
    7. Reimbursement Scenario in Europe
  5. Europe Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032 
    1. Market Analysis, Insights and Forecast – By Type
      1. Drugs
        1. Prescription
        2. OTC
      2. Vaccines
        1. Bacterial
        2. Viral
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Oncology
      2. Diabetes
      3. Infectious
      4. Cardiovascular
      5. Neurology & Psychiatry
      6. Respiratory
      7. Renal
      8. Obesity
      9. Autoimmune
      10. Ophthalmic
      11. Gastrointestinal
      12. Dermatology
      13. Hematology/Blood
      14. Liver/Hepatology
      15. Genetic
      16. Hormonal/Endocrine
      17. Women’s Health
      18. Reproductive
      19. Allergies
      20. Others
    3. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics & Biosimilars
        1. Antibodies
          1. Monoclonal Antibodies (mAbs)
          2. Bispecific Antibodies
          3. Antibody-Drug Conjugates (ADCs)
          4. Others
        2. Vaccines
        3. Peptides/Peptide-Drug Conjugates (PDCs)
        4. Others
      2. Small Molecules/Conventional Drugs
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
      4. Inhalation
      5. Others
    5. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies 
    7. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K. 
      2. Germany 
      3. France 
      4. Spain 
      5. Italy 
      6. Scandinavia 
      7. Rest of Europe 
  6. Competitive Analysis 
    1. Europe Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Merck & Co., Inc.
      2. Pfizer Inc.
      3. Johnson & Johnson
      4. AbbVie Inc.
      5. AstraZeneca
      6. F. Hoffmann-La Roche Ltd
      7. Novartis AG
      8. Bristol-Myers Squibb Company
      9. Eli Lilly and Company
      10. Sanofi
      11. Novo Nordisk A/S
      12. GSK plc.
      13. Amgen Inc.
      14. Gilead Sciences, Inc.
      15. Takeda Pharmaceutical Company Limited 
      16. Other Prominent Players
Read Less

Figure 1: Europe Pharmaceuticals Market Revenue Breakdown (USD Billion, %), By Type, 2024 & 2032

Figure 2: Europe Pharmaceuticals Market Value Share (%), by Type, 2024 & 2032

Figure 3: Europe Pharmaceuticals Market Value Share (%), by Indication, 2024 & 2032

Figure 4: Europe Pharmaceuticals Market Value Share (%), by Drug Type, 2024 & 2032

Figure 5: Europe Pharmaceuticals Market Value Share (%), by Route of Administration, 2024 & 2032

Figure 6: Europe Pharmaceuticals Market Value Share (%), by Age Group, 2024 & 2032

Figure 7: Europe Pharmaceuticals Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 8: Europe Pharmaceuticals Market Value Share (%), by Country/Sub-region, 2024 & 2032

Figure 9: Europe Pharmaceuticals Market Share (%), By Company, 2024

Table 1: Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Type, 2019–2032

Table 2: Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drugs, 2019–2032

Table 3: Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Vaccines, 2019–2032

Table 4: Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Disease Indication, 2019–2032

Table 5: Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drug Type, 2019–2032

Table 6: Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Biologics & Biosimilars, 2019–2032

Table 7: Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Antibodies, 2019–2032

Table 8: Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Route of Administration, 2019–2032

Table 9: Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Age Group, 2019–2032

Table 10: Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2032

Table 11: Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Country/Sub-region , 2019–2032

Table 12: Germany Pharmaceuticals Market Revenue (USD Billion) Forecast, by Type, 2019–2032

Table 13: Germany Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drugs, 2019–2032

Table 14: Germany Pharmaceuticals Market Revenue (USD Billion) Forecast, by Vaccines, 2019–2032

Table 15: Germany Pharmaceuticals Market Revenue (USD Billion) Forecast, by Disease Indication, 2019–2032

Table 16: Germany Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drug Type, 2019–2032

Table 17: Germany Pharmaceuticals Market Revenue (USD Billion) Forecast, by Biologics & Biosimilars, 2019–2032

Table 18: Germany Pharmaceuticals Market Revenue (USD Billion) Forecast, by Antibodies, 2019–2032

Table 19: Germany Pharmaceuticals Market Revenue (USD Billion) Forecast, by Route of Administration, 2019–2032

Table 20: Germany Pharmaceuticals Market Revenue (USD Billion) Forecast, by Age Group, 2019–2032

Table 21: Germany Pharmaceuticals Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2032

Table 22: UK Pharmaceuticals Market Revenue (USD Billion) Forecast, by Type, 2019–2032

Table 23: UK Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drugs, 2019–2032

Table 24: UK Pharmaceuticals Market Revenue (USD Billion) Forecast, by Vaccines, 2019–2032

Table 25: UK Pharmaceuticals Market Revenue (USD Billion) Forecast, by Disease Indication, 2019–2032

Table 26: UK Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drug Type, 2019–2032

Table 27: UK Pharmaceuticals Market Revenue (USD Billion) Forecast, by Biologics & Biosimilars, 2019–2032

Table 28: UK Pharmaceuticals Market Revenue (USD Billion) Forecast, by Antibodies, 2019–2032

Table 29: UK Pharmaceuticals Market Revenue (USD Billion) Forecast, by Route of Administration, 2019–2032

Table 30: UK Pharmaceuticals Market Revenue (USD Billion) Forecast, by Age Group, 2019–2032

Table 31: UK Pharmaceuticals Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2032

Table 32: France Pharmaceuticals Market Revenue (USD Billion) Forecast, by Type, 2019–2032

Table 33: France Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drugs, 2019–2032

Table 34: France Pharmaceuticals Market Revenue (USD Billion) Forecast, by Vaccines, 2019–2032

Table 35: France Pharmaceuticals Market Revenue (USD Billion) Forecast, by Disease Indication, 2019–2032

Table 36: France Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drug Type, 2019–2032

Table 37: France Pharmaceuticals Market Revenue (USD Billion) Forecast, by Biologics & Biosimilars, 2019–2032

Table 38: France Pharmaceuticals Market Revenue (USD Billion) Forecast, by Antibodies, 2019–2032

Table 39: France Pharmaceuticals Market Revenue (USD Billion) Forecast, by Route of Administration, 2019–2032

Table 40: France Pharmaceuticals Market Revenue (USD Billion) Forecast, by Age Group, 2019–2032

Table 41: France Pharmaceuticals Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2032

Table 42: Italy Pharmaceuticals Market Revenue (USD Billion) Forecast, by Type, 2019–2032

Table 43: Italy Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drugs, 2019–2032

Table 44: Italy Pharmaceuticals Market Revenue (USD Billion) Forecast, by Vaccines, 2019–2032

Table 45: Italy Pharmaceuticals Market Revenue (USD Billion) Forecast, by Disease Indication, 2019–2032

Table 46: Italy Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drug Type, 2019–2032

Table 47: Italy Pharmaceuticals Market Revenue (USD Billion) Forecast, by Biologics & Biosimilars, 2019–2032

Table 48: Italy Pharmaceuticals Market Revenue (USD Billion) Forecast, by Antibodies, 2019–2032

Table 49: Italy Pharmaceuticals Market Revenue (USD Billion) Forecast, by Route of Administration, 2019–2032

Table 50: Italy Pharmaceuticals Market Revenue (USD Billion) Forecast, by Age Group, 2019–2032

Table 51: Italy Pharmaceuticals Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2032

Table 52: Spain Pharmaceuticals Market Revenue (USD Billion) Forecast, by Type, 2019–2032

Table 53: Spain Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drugs, 2019–2032

Table 54: Spain Pharmaceuticals Market Revenue (USD Billion) Forecast, by Vaccines, 2019–2032

Table 55: Spain Pharmaceuticals Market Revenue (USD Billion) Forecast, by Disease Indication, 2019–2032

Table 56: Spain Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drug Type, 2019–2032

Table 57: Spain Pharmaceuticals Market Revenue (USD Billion) Forecast, by Biologics & Biosimilars, 2019–2032

Table 58: Spain Pharmaceuticals Market Revenue (USD Billion) Forecast, by Antibodies, 2019–2032

Table 59: Spain Pharmaceuticals Market Revenue (USD Billion) Forecast, by Route of Administration, 2019–2032

Table 60: Spain Pharmaceuticals Market Revenue (USD Billion) Forecast, by Age Group, 2019–2032

Table 61: Spain Pharmaceuticals Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2032

Table 62: Scandinavia Pharmaceuticals Market Revenue (USD Billion) Forecast, by Type, 2019–2032

Table 63: Scandinavia Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drugs, 2019–2032

Table 64: Scandinavia Pharmaceuticals Market Revenue (USD Billion) Forecast, by Vaccines, 2019–2032

Table 65: Scandinavia Pharmaceuticals Market Revenue (USD Billion) Forecast, by Disease Indication, 2019–2032

Table 66: Scandinavia Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drug Type, 2019–2032

Table 67: Scandinavia Pharmaceuticals Market Revenue (USD Billion) Forecast, by Biologics & Biosimilars, 2019–2032

Table 68: Scandinavia Pharmaceuticals Market Revenue (USD Billion) Forecast, by Antibodies, 2019–2032

Table 69: Scandinavia Pharmaceuticals Market Revenue (USD Billion) Forecast, by Route of Administration, 2019–2032

Table 70: Scandinavia Pharmaceuticals Market Revenue (USD Billion) Forecast, by Age Group, 2019–2032

Table 71: Scandinavia Pharmaceuticals Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2032

Table 72: Rest of Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Type, 2019–2032

Table 73: Rest of Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drugs, 2019–2032

Table 74: Rest of Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Vaccines, 2019–2032

Table 75: Rest of Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Disease Indication, 2019–2032

Table 76: Rest of Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drug Type, 2019–2032

Table 77: Rest of Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Biologics & Biosimilars, 2019–2032

Table 78: Rest of Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Antibodies, 2019–2032

Table 79: Rest of Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Route of Administration, 2019–2032

Table 80: Rest of Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Age Group, 2019–2032

Table 81: Rest of Europe Pharmaceuticals Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2032

Europe Pharmaceuticals Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 220
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports